ArticleChemistry & biodiversity2026
Rosa rubiginosa L. Extract Rich in Bioactive Phenolics Possess Potent Anti-Inflammatory, Antioxidant, Photoprotective, and Antimicrobial Biofunctional Activities.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The hydroethanolic Rosa rubiginosa extract is evaluated in vitro for antioxidant, anti-inflammatory, antiplatelet, photoprotective, and antimicrobial activities. Rich in phenolics and carotenoids, it shows strong antioxidant activity (notably in DPPH) and high SPF-related UV protection. Major compounds include rosmarinic acid, hydroxybenzoic acid, quercetin, and luteolin. Synergistic interactions among bioactives enhance antioxidant capacity beyond that of individual compounds. The extract demonstrates pronounced anti-inflammatory effects against platelet-activating factor (PAF), exceeding those of isolated standards, while showing lower activity against ADP-induced platelet aggregation, indicating specificity toward PAF-mediated pathways. Molecular docking supports interactions with the PAF receptor. Given PAF's role in UV-induced inflammation and melanoma, the extract's UV absorption, antioxidant capacity, and anti-PAF activity suggest protective effects against photoaging. Antimicrobial activity is stronger against Gram-negative bacteria, with slower effects on Gram-positive strains. Overall, R. rubiginosa extract exhibits broad bioactivity, supporting its potential as a multifunctional ingredient in functional foods, nutraceuticals, supplements, and cosmetic formulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.